Rydar Equities’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Rydar Equities's LLY Position: Q1 2026 in Review
Rydar Equities increased its Eli Lilly (LLY) stake by 0.19% in Q1 2026, buying an estimated $3.04K and bringing the position to 1,565 shares worth $1.44M. The position accounts for 1.11% of the portfolio, ranked #32.
Rydar Equities first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.68M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Rydar Equities held 1,565 shares of Eli Lilly worth $1.44M as of Q1 2026.
- Rydar Equities bought 3 Eli Lilly shares in Q1 2026, an estimated $3.04K.
- Eli Lilly made up 1.11% of Rydar Equities's portfolio in Q1 2026, its #32 holding.
- Rydar Equities first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
- Rydar Equities's Eli Lilly position peaked at $1.68M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Rydar Equities's 13F filing for Q1 2026, filed 13 Apr 2026.